Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Socorro O Portella
Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI): Real World Evidence From 26 US Institutions
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Highly Fluctuating Thrombocytopenia Developing in a Patient With Immune Thrombocytopenia (ITP) While Administering Romiplostim
Internal Medicine
Internal Medicine
Medicine
Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia
American Journal of Hematology
Hematology
Self-Administration of Romiplostim in Patients With Chronic Immune Thrombocytopenia
Community Oncology
Relative Potency of the Thrombopoietin Receptor Agonists Eltrombopag, Avatrombopag and Romiplostim in a Patient With Chronic Immune Thrombocytopenia
British Journal of Haematology
Hematology
Eltrombopag in Preparation for Surgery in Patients With Severe Myh9 ‐Related Thrombocytopenia
American Journal of Hematology
Hematology
The Efficacy and Safety of Romiplostim in Adult Patients With Chronic Immune Thrombocytopenia
Therapeutic Advances in Hematology
Hematology
Determining the Cost of a Bleeding-Related Episode in Primary Adult Chronic Immune Thrombocytopenia (ITP) in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Eltrombopag-Based Combination Treatment for Immune Thrombocytopenia
Therapeutic Advances in Hematology
Hematology
